Skip to main content

Table 1 Patient and tumor characteristics

From: Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost

Characteristic

No. of patients (%) (N = 37)

Age (median)

60 (35–82)

Gender

 

 Male

25 (68%)

 Female

12 (32%)

Primary site

 

 Floor of the mouth

31 (84%)

 Oral tongue

6 (16%)

ECOG performance status

 

 0

25 (68%)

 1

12 (32%)

T stage

 

 2

3 (8%)

 3

10 (27%)

 4

24 (65%)

N stage

 

 0

5 (14%)

 1

4 (11%)

 2a

4 (11%)

 2b

6 (16%)

 2c

16 (43%)

3

2 (5%)

Histology

 

 Squamous cell carcinoma HPV negative

37 (100%)

Tumor grading

 

 Gr.1

25 (68%)

 Gr.2

10 (27%)

 Gr.3

2(5%)

SRT boost TU volume (median)

43,98cm3 (23.4–89.4)

  1. ECOG Eastern cooperative oncology group